Coming up: Facial rashes case studies
What does it mean when a facial red rash does not respond to topical steroids?
Reporting from The Medical Republic (medicalrepublic.com.au), carried via the publisher’s public feed.
What does it mean when a facial red rash does not respond to topical steroids?
Bulk billing assignment of benefit is a complex thing. The good news is, it’s about to get more complicated.

The man running one of the world’s most consequential health data platforms – the Mayo Platform – is speaking at the Wild Health summit in Canberra next month to set out, in concrete terms, how you can actually move a…

CBT and mindfulness showed little added benefit after initial treatment failure.

Melbourne clinicians have identified a key barrier to phage therapy and a workaround.
You have eight weeks to get your two cents in.

A national survey suggests up to 488,000 Australians may live with alopecia areata, with many self-diagnosing and going untreated despite significant psychological distress.

Mineralocorticoid receptor antagonists (MRAs) are one of the four pillars of heart failure management.
Four Australian jurisdictions have released public health alerts as infection numbers soar.

The monoclonal antibody therapy has been proven to reduce potentially life-threatening episodes of angioedema.
A thin plastic film that rips apart viruses? What’s not to like!
The health minister has indicated that GLP-1 RAs will eventually join the PBS, so can we expect commensurate funding for lifestyle interventions?

Listen to what breast density means for individual risk and how results should be interpreted.
With the right formulation and a little bit of laser therapy, needle-free administration of botulinum toxin is possible.

Proponents of ‘neuropreservation’ get a little ahead of themselves.
Research shows nearly three in ten Australian women describe their latest birth as 'traumatic' - what can be done to overcome this?
Cutting out mandatory GP reconnection points is almost certainly a bad idea.

The announcement of a national pharmacist prescribing trial sparked backlash from GPs and rural pharmacist bodies alike.

But one of the biggest rural medical advocacy bodies was kept out of the loop.

The department wants it both ways, forbidding clinical assessors from correcting the IAT’s mistakes and then saying it’s the assessors’ fault if the IAT makes the mistake in the first place. Come on.

The integration is intended to give practices of all sizes access to next-generation workflow support. It’s a big move, say GPs.

While not life-threatening, allergic rhinitis can make a child's life miserable.
The new drug led to significantly improved survival in patients with hard-to-treat cancer, prompting a fast-track approval process in the US.